It is HSA/FSA eligible and available across all 50 states without insurance
As of December 2025, there are no peer-reviewed trials directly examining whether a GLP-1 agonist helps or harms exercise performance in athletes
Research has shown that activating both pathways may lead to: Greater appetite suppression Improved insulin sensitivity Enhanced fat metabolism More significant overall weight loss Because of this mechanism, tirzepatide has attracted attention as one of the most powerful medications currently available for medical weight management
Insulin resistance constitutes an important mechanistic link between prolactin abnormalities and obesity-related metabolic disorders, and is a core pathological feature of metabolic syndrome and type 2 diabetes ( A hyperglycemic clamp test showed that individuals with higher circulating prolactin levels had significantly reduced insulin sensitivity ( 4.4 Hypothalamicpituitarygonadal axis disruption The HPG axis is extremely sensitive to circulating prolactin levels
What the Future Holds for Cagrilintide Ongoing studies are assessing long-term cardiovascular outcomes , weight loss durability, and real-world adherence
For glycaemic control in people with type 2 diabetes, liraglutide doses above 1.8 mg once daily provide no substantial additional benefit